These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The biologic role of components of the plasminogen-plasmin system. Kwaan HC Prog Cardiovasc Dis; 1992; 34(5):309-16. PubMed ID: 1531879 [No Abstract] [Full Text] [Related]
4. Urinary tissue type plasminogen activator and plasminogen activator inhibitor in renal transplant patients. Ikegami M; Ishii T; Uemura T; Kunikata S; Matsuura T; Akiyama T; Kurita T Transplant Proc; 1992 Aug; 24(4):1547-8. PubMed ID: 1496654 [No Abstract] [Full Text] [Related]
5. Regulation of the plasminogen activator system in non-small cell lung cancer cell lines by growth factors EGF, TGF-alpha and TGF-beta. Heidtmann HH; Havemann K; Schwartz-Albiez R Br J Cancer; 1992 Feb; 65(2):154-6. PubMed ID: 1310869 [No Abstract] [Full Text] [Related]
6. Plasminogen activator and its inhibitor in the experimental corneal wound. Tervo T; Tervo K; van Setten GB; Virtanen I; Tarkkanen A Exp Eye Res; 1989 Mar; 48(3):445-9. PubMed ID: 2494049 [TBL] [Abstract][Full Text] [Related]
7. Regulation and interactions in the activation of cell-associated plasminogen. Myöhänen H; Vaheri A Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213 [TBL] [Abstract][Full Text] [Related]
8. The role of the pericellular fibrinolytic system in angiogenesis. Fukao H; Ueshima S; Okada K; Matsuo O Jpn J Physiol; 1997 Apr; 47(2):161-71. PubMed ID: 9201545 [No Abstract] [Full Text] [Related]
9. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines. Quax PH; van Leeuwen RT; Verspaget HW; Verheijen JH Cancer Res; 1990 Mar; 50(5):1488-94. PubMed ID: 2105839 [TBL] [Abstract][Full Text] [Related]
10. Fibrinolysis: the key to new pathogenetic mechanisms. Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800 [TBL] [Abstract][Full Text] [Related]
11. The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells. Tienari J; Alanko T; Lehtonen E; Saksela O Cell Regul; 1991 Apr; 2(4):285-97. PubMed ID: 1905574 [TBL] [Abstract][Full Text] [Related]
12. Production of proteases type plasminogen activator and their inhibitor in cornea. Mirshahi M; Mirshahi S; Soria C; Soria J; Thomaidis A; Pouliquen Y; Faure JP Biochem Biophys Res Commun; 1989 May; 160(3):1021-5. PubMed ID: 2499321 [TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH; Martin TJ J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231 [TBL] [Abstract][Full Text] [Related]
14. Decreased tissue plasminogen activator and increased plasminogen activator inhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine. Pelayo BA; Fu YM; Meadows GG Int J Oncol; 2001 Apr; 18(4):877-83. PubMed ID: 11251188 [TBL] [Abstract][Full Text] [Related]
15. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis]. Matsuda T Rinsho Byori; 1985 Sep; 33(9):982-8. PubMed ID: 2416968 [No Abstract] [Full Text] [Related]